CLINICAL

STUDIES

Learn about some clinical studies that have been involved by Science Valley:

TREATMENT

MICHELLE

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy

ClinicalTrials.gov Identifier: 
NCT04662684

KNOW MORE

 

TREATMENT

STRUCK TRIAL

Survival Trial Using CytoKines 

ClinicalTrials.gov Identifier: 
NCT04724629

KNOW MORE

 

TREATMENT

BTK

Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19

ClinicalTrials.gov Identifier:
NCT04528667

KNOW MORE

 

TREATMENT

COMET-ICE

VIR-7831 for the Early Treatment of COVID-19 in Outpatients

ClinicalTrials.gov Identifier: 
NCT04545060

KNOW MORE

 

VACCINE

CLINERGY

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19)

ClinicalTrials.gov Identifier:
NCT04510207

KNOW MORE

 

VACCINE

CLOVER

Clostridium Difficile Vaccine Efficacy Trial

ClinicalTrials.gov Identifier:
NCT03090191

KNOW MORE

 

STRATEGIC PORTFOLIO

VALERIA

Efficacy and safety of rivaroxaban 10 mg once daily versus enoxaparin 40 mg once daily for prophylaxis of venous thromboembolism in gynecological cancer surgery.

ClinicalTrials.gov Identifier:  
In Progress

STRATEGIC PORTFOLIO

AGRIPPA

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients

ClinicalTrials.gov Identifier: 
NCT04229264

KNOW MORE